A Cohort-Based Case Report
The Impact of Ketamine-Assisted Therapy Embedded in a Community of Practice Framework for Healthcare Providers With PTSD and Depression:
Safety and tolerability of intramuscular and sublingual ketamine for psychiatric treatment in the Roots To Thrive ketamine-assisted therapy program
What the research says
The enclosed data includes the participants who screened positive for PTSD, depression, or generalized anxiety disorder upon entry into the RTT-KaT program. The pre-results were taken within 1 month of the program beginning and post-results were taken directly after the 12-week program was completed.
PTSD
Of 37 participants, 32 screened negative for PTSD following our 12-week program, resulting in an 86% success rate.
Generalized Anxiety
Of 55 participants, 50 went into a milder category or showed significant clinical improvements following our 12-week program, resulting in a 91% success rate.
Depression
Of 62 participants, 49 went into a milder category or showed significant clinical improvements following our 12-week program, resulting in a 79% success rate.
Life work functionality
Of 65 participants with significant impairment, 60 reported significant improvements following our 12-week program, resulting in a 92% success rate.
